LORIS

From Ganfyd

Jump to: navigation, search
Name of Trial: LORIS
Full Name
A Phase III trial of surgery versus active monitoring for LOw RISk Ductal Carcinoma in situ
Type of Trial
RCT
Studied
Incidental or screening-detected low or intermediate grade DCIS randomised to either a no surgical intervention (active monitoring) or surgery
Primary Outcome
Ipsilateral invasive breast cancer free survival rate at 5 years
Other Outcomes
Overall survival; mastectomy rate; time to mastectomy; time to surgery; patient reported outcomes; health resource utilisation and assessment of predictive biomarkers.
Summary
On-going.
Criticisms and Limitations
Clinical Trial Websites
Relevant Clinical Literature

See: http://www.abstracts2view.com/sabcs13/view.php?nu=SABCS13L_412

References

Personal tools